FDA
-
-
-
-
-
-
-
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
-
-
-
-
-
-
-
Alpine Immune Sciences Terminates Enrollment of Davoceticept Clinical Studies (NEON-1 and NEON-2)
-
-
-
-
-
-
-
Alpine Immune Sciences (ALPN) Announces FDA Placed Partial Clinical Hold on NEON-2 Trial of Davoceticept in Combination with Pembrolizumab
-
-
-
-
-
-
-
Angion Completes Equity Financing and Appoints Senior Executives
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

